In the context of cancer, including pancreatic ductal adenocarcinoma, increased levels of Gal-1 have been detected in both plasma and serum, in conjunction with overexpression in tumor tissues [22]. This evidence concerns the gene LGALS1 and pancreatic ductal adenocarcinoma.